Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01CAH
|
|||
| Drug Name |
Mesenchymal stem cells
|
|||
| Synonyms |
MSCs
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Epidermolysis bullosa [ICD-11: EC3Z] | Approved | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (FDA ORPHAN DRUG) 427014 | |||
| REF 2 | ClinicalTrials.gov (NCT04288102) Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.